Operator Protection as Core Design Principle for ADC Bioprocessing

As antibody-drug conjugates gain momentum in biopharma, manufacturers face a crucial challenge: protecting operators from exposure to highly potent compounds while maintaining aseptic processing, containment standards, and efficient commercial-scale production. The post Operator Protection as Core Design Principle for ADC Bioprocessing appeared first on GEN - Genetic Engineering and Biotechnology News .